Procollagenblood test The procollagen 3 N-terminal peptide, often referred to as PIIINP or P3NP, is a crucial indicator related to the synthesis of type III collagen. This amino-terminal peptide is released from the procollagen precursor during the process of type III collagen formation and deposition within tissues.The decision to perform biopsy, withdraw treatment, or continue treatment despite raised PIIINP concentrations, must also take into account other factors, such ... Measuring circulating levels of PIIINP in the blood provides valuable insights into the body's collagen synthesis activity and can serve as a biomarker for various conditions, particularly those involving fibrosisThis assay has high sensitivity and excellent specificity for detection ofProcollagen III N-Terminal Propeptide(PIIINP).. Understanding PIIINP is essential for assessing tissue remodeling, monitoring treatment efficacy, and diagnosing certain disease states.
Collagen is the most abundant protein in mammals, playing a vital structural role in connective tissues. Type III collagen, in particular, is a key component of skin, blood vessels, and internal organs, contributing to their elasticity and structural integrity. The synthesis of type III collagen involves the production of a precursor molecule, procollagen, which is then processed before being incorporated into the extracellular matrix. During this processing, specific peptides, including the N-terminal propeptide (PIIINP), are cleaved from the procollagen molecule and released into the circulationIt provides anon-invasive means of monitoring methotrexate treated psoriatics, thereby reducing the need of liver biopsies..
The concentration of PIIINP in the blood generally reflects the rate of type III collagen synthesis throughout the body. Elevated levels of PIIINP can indicate increased collagen production, which may be a response to tissue damage, inflammation, or the development of fibrotic processes作者：SD Berry·2013·被引用次数：43—Our results suggest thatplasma P3NP might be a useful biomarker of muscle massin postmenopausal women if longitudinal studies demonstrate that it has .... Conversely, lower levels might suggest reduced collagen synthesisProcollagen Type I Intact N Terminal Propeptide | Test Detail.
One of the most significant applications of PIIINP measurement is in the assessment of fibrosis, a condition characterized by the excessive accumulation of extracellular matrix proteins, including collagen, in tissues. Fibrosis can impair organ function and is a hallmark of many chronic diseases.
* Liver Fibrosis: PIIINP has been extensively studied as a biomarker for liver fibrosis and cirrhosis.P3NP: Procollagen Type 3 Amino Terminal Peptide Test Elevated serum PIIINP levels can indicate increased collagen synthesis in the liver, suggesting the presence or progression of fibrotic changes. This is particularly relevant in monitoring patients with liver diseases of various etiologies.作者：JG Clark·1994·被引用次数：15—Elevated Lavage Levels ofN-Terminal Peptide of Type III ProcollagenAre Associated With Increased Fatality in Adult Respiratory Distress Syndrome.
* Methotrexate Monitoring: For patients undergoing treatment with methotrexate, a medication often used for autoimmune conditions like psoriasis and rheumatoid arthritis, PIIINP measurement is advised. Methotrexate can potentially lead to liver fibrosis, and elevated PIIINP levels serve as a non-invasive indicator of hepatic fibrosis, helping clinicians manage treatment dosage and potentially reducing the need for liver biopsies.N-terminal propeptide of procollagen type III (PIIINP) and ...
* Other Tissues: Research also suggests that circulating PIIINP levels may reflect fibrosis in other tissues, including skeletal muscle, and can be associated with increased fatality in conditions like Adult Respiratory Distress SyndromeProcollagen type III N-terminal peptide (P3NP) and lean mass.
The PIIINP test is a quantitative measurement of the serum level of this peptide and is utilized in various clinical contexts.The P3NP-EL-US test enables the determination ofhuman procollagen III peptide (P3NP) in blood for fibrosis research. View product information.
* Scar Formation: PIIINP can be elevated transiently following acute tissue damage, acting as a marker of scar formationP3NP Exeter Clinical Laboratory International. In such cases, follow-up measurements may be recommended to track the healing process. Persistent elevation can indicate chronic fibrotic activityTest Guide - Procollagen 3 (N-Terminal Peptide).
* Aging and Muscle Mass: Some studies suggest that plasma P3NP might be a useful biomarker related to muscle mass, particularly in postmenopausal women, indicating a potential link between collagen turnover and age-related changes in body compositionSerum levels of N-terminal type III procollagen peptide in ....
* Ehlers-Danlos Syndrome: Defects in the gene coding for type III collagen (COL3A1) are associated with Ehlers-Danlos syndrome type 3 (EDS3), a group of inherited connective tissue disorders. While PIIINP directly measures collagen synthesis, its role in diagnosing or managing EDS3 requires further context.
When interpreting PIIINP levels, it's crucial to consider other clinical factors, such as the patient's medical history, other laboratory results, and imaging findingsProcollagen‐3 N‐terminal peptide measurements for the .... Decisions regarding treatment, biopsy, or further interventions should take into account a comprehensive assessment rather than relying solely on PIIINP values.
In summary, the procollagen 3 N-terminal peptide (PIIINP) is a significant biomarker that offers a window into type III collagen synthesis and the presence of fibrotic processes in various tissues. Its utility in monitoring liver fibrosis, managing methotrexate therapy, and assessing tissue remodeling makes it a valuable tool in clinical diagnostics and patient management.
Join the newsletter to receive news, updates, new products and freebies in your inbox.